Ketamine One (NEO:MEDI.AQN) Interim CEO Adam Deffett joined Stephen Gunnion from Proactive with news of an exclusive agreement with OVR Tech LLC to provide its INHALE Wellness Platform during an initial two-year term in its clinics.
Deffett telling Proactive that the deal has the potential to lead to clinically validated solutions for use in its facilities as well as patients' homes through the development of a portable digital therapeutic offering in the future.